Dr. OttoHertzberg

Associate

Frankfurt + 49.69.9726.3804

Dr. Otto Hertzberg is a German and European Patent Attorney and biophysicist. Otto has a broad scientific background and works on patent prosecution and litigation matters in various fields of technology including physics, biophysics, medical physics and engineering, mechanical and electrical engineering, computer-implemented inventions, biomedical inventions, and inventions related to medical devices. He is also involved in prosecution of patent applications and litigation proceedings for clients in the areas of telecommunications and wireless devices.

Prior to joining Jones Day in 2019, Otto was a researcher at the Institute of Biophysics at Goethe-University Frankfurt. His research focused on biomedical infrared spectroscopy in combination with photothermal sensing techniques and on the development of new spectroscopic set-ups suitable for in vivo measurement/clinical application. As part of his research he also implemented multivariate/machine learning procedures (e.g., principal component analysis [PCA] and partial least squares regression [PLSR]) for the calibration and test set validation of data from in vitro and in vivo samples.

Otto was also a member of a technology transfer project at a start-up company in Berlin, where he worked on the commercialization of photothermal infrared spectroscopic techniques for noninvasive substance analysis for clinical application.

Otto has participated in and presented his work at several international conferences focusing on biomedical spectroscopy, photothermal and photoacoustic phenomena, biophysics, and clinical spectroscopy.

Experience

  • Valmet acquires process gas chromatography business of Siemens AGJones Day advised Valmet Oyj in the €102.5 million acquisition of the process gas chromatography business of Siemens AG.
  • Cylance builds leading patent portfolio directed to cybersecurity technologies using AIJones Day is representing Cylance Inc. in the development and prosecution of a portfolio of over 150 issued patents directed to AI-enabled cybersecurity technologies.